Igentify

Digital Platform for Genetic Counseling and Testing

Health Tech & Life Sciences
Active
Series B Caesarea Founded 2016
Total raised
$38.4M
Last: Undisclosed 2024-07
Stage
Series B
Founded
2016
Headcount
52
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Igentify is a digital health company and the developer of the Digital Genetic Counselor, a digital platform for genetic test providers. The platform provides a fully scalable end-to-end genetic counseling solution for both clinical and non-clinical (direct-to-consumer) genetic testing applications. The Igentify platform is developed for a variety of genotyping technologies, including microarray and next-generation sequencing (NGS), and can be customized to a broad spectrum of genetic or genomic tests offered by the test providers. The platform provides consumers with an exceptional user experience, from enrollment and personalized consent for the genetic test to the automated delivery of machine-generated personalized genetic counseling. In January 2019, Igentify was selected by Deloitte as one of the Israeli start-ups at the forefront of the digital R&D revolution.

Funding history · 6 rounds · $38.4M total

2024-07
Undisclosed Undisclosed
2022-01
Series B $7.0M
2020-03
Series B $12.2M
2019-09
Series A $10.5M
2018-05
Seed $4.0M
2016-12
Seed $3.2M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPatient Engagement
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLaboratories
Business model
B2B2CB2B

Highlights

1 Patents

Tags

cloud-basedscreeninghealthcare-providershealth-informationdiagnosticsbioinformaticspreventiongeneticsgenomicsblood-testbiotechnologymedical-technologieslaboratoriesartificial-intelligencepatient-engagementhospitalsprecision-medicinedigital-healthcarepatientsinsurance-companiespersonalizationclinics